Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)
China
· Delayed Price · Currency is CNY 23.10
-0.38 (-1.62%)
Mar 10, 2026, 3:00 PM CST
SHA:600513 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -43.6 | 84.16 | 135.01 | 141.37 | 118.84 | 103 | Upgrade
|
| Depreciation & Amortization | 60.39 | 60.39 | 56.48 | 40.81 | 28.05 | 22.1 | Upgrade
|
| Other Amortization | 1.61 | 1.61 | 1.47 | 1.35 | 0.95 | 0.91 | Upgrade
|
| Loss (Gain) From Sale of Assets | -35.03 | -35.03 | -8.89 | 0.01 | - | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.11 | 0.11 | 0.99 | 0.02 | 0.06 | 0.12 | Upgrade
|
| Loss (Gain) From Sale of Investments | 9.12 | 9.12 | -0.19 | 2.86 | -0.23 | 0.22 | Upgrade
|
| Provision & Write-off of Bad Debts | 6.72 | 6.72 | 2.57 | 7.85 | - | - | Upgrade
|
| Other Operating Activities | -15.95 | 53.22 | 46.49 | 49.18 | 44.33 | 38.19 | Upgrade
|
| Change in Accounts Receivable | -60.14 | -60.14 | -47.4 | -130.55 | -56.96 | -121.13 | Upgrade
|
| Change in Inventory | -134.27 | -134.27 | -38.61 | -77.31 | -12.67 | 40.7 | Upgrade
|
| Change in Accounts Payable | 23.34 | 23.34 | 20.36 | 102.66 | 16.36 | 3.21 | Upgrade
|
| Change in Other Net Operating Assets | - | - | -4.24 | 1.2 | -1.38 | 2.91 | Upgrade
|
| Operating Cash Flow | -186.16 | 10.77 | 160.7 | 127.59 | 138.34 | 91.94 | Upgrade
|
| Operating Cash Flow Growth | - | -93.30% | 25.95% | -7.77% | 50.48% | - | Upgrade
|
| Capital Expenditures | -216.69 | -184.85 | -200.67 | -220.68 | -172.11 | -174.18 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0.01 | 26.48 | - | 0.97 | 22.02 | Upgrade
|
| Cash Acquisitions | - | - | -1.75 | - | - | - | Upgrade
|
| Divestitures | - | - | - | - | -7.38 | 0.52 | Upgrade
|
| Investment in Securities | -125.01 | - | -8.76 | - | 0.06 | 0.07 | Upgrade
|
| Other Investing Activities | 0.01 | 0.01 | 0 | - | 1.03 | 22.33 | Upgrade
|
| Investing Cash Flow | -341.67 | -184.83 | -184.69 | -220.68 | -177.43 | -129.24 | Upgrade
|
| Long-Term Debt Issued | - | 847.98 | 698.08 | 792 | 606.5 | 395.5 | Upgrade
|
| Total Debt Issued | 1,539 | 847.98 | 698.08 | 792 | 606.5 | 395.5 | Upgrade
|
| Long-Term Debt Repaid | - | -674.64 | -630.88 | -662.8 | -425.59 | -339 | Upgrade
|
| Total Debt Repaid | -907.5 | -674.64 | -630.88 | -662.8 | -425.59 | -339 | Upgrade
|
| Net Debt Issued (Repaid) | 631.39 | 173.33 | 67.19 | 129.2 | 180.91 | 56.5 | Upgrade
|
| Repurchase of Common Stock | - | - | -6.26 | -3.36 | - | -0.48 | Upgrade
|
| Common Dividends Paid | -52.14 | -50.57 | -51.23 | -54.4 | -39.79 | -42.5 | Upgrade
|
| Other Financing Activities | 7.59 | -12.83 | -44.81 | 5.49 | 0.43 | - | Upgrade
|
| Financing Cash Flow | 586.84 | 109.94 | -35.1 | 76.92 | 141.55 | 13.52 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.69 | 0.63 | 0.23 | 2.31 | -0.79 | -1.65 | Upgrade
|
| Net Cash Flow | 59.7 | -63.5 | -58.86 | -13.86 | 101.67 | -25.43 | Upgrade
|
| Free Cash Flow | -402.85 | -174.08 | -39.96 | -93.09 | -33.77 | -82.24 | Upgrade
|
| Free Cash Flow Margin | -15.50% | -8.06% | -1.84% | -4.76% | -2.05% | -5.93% | Upgrade
|
| Free Cash Flow Per Share | -1.38 | -0.60 | -0.14 | -0.32 | -0.12 | -0.29 | Upgrade
|
| Cash Income Tax Paid | 207.49 | 190.67 | 170.66 | 153.63 | 124.97 | 110.28 | Upgrade
|
| Levered Free Cash Flow | -520.05 | -319.57 | -65.42 | -137.36 | -73.41 | -123.89 | Upgrade
|
| Unlevered Free Cash Flow | -500.97 | -303.98 | -48.73 | -121.62 | -61.47 | -113.38 | Upgrade
|
| Change in Working Capital | -169.53 | -169.53 | -73.23 | -115.87 | -53.65 | -72.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.